A well -known researcher in cancer metabolism
Dr. Seyfried received his doctorate. In the field of genetics and biochemistry at the University of Illinois and graduated from the doctoral studies at the Department of Neurology at the Yale Medical School. He is now a professor of Boston College, where he studies the methods of cellular energy metabolism can attract cancer, epilepsy and development of neurodegenerative diseases.His pioneer book “Cancer as a Metabolic Disease”, released in 2012, offers scientific evidence that mitochondrial breakdown is not a genetic mutation – is the main cause of most crayfish.
What does his experience say?
Glucose: It nourishes your tumor
Dr. Sesfried claims that glucose is the main fuel for cancer cells. Unlike healthy cells that have flexibility for the cycle between sugar burning and fat, cancer cells are almost completely dependent on sugar. This characteristic makes them sensitive to interventions that reduce blood glucose, including ketogenic diets or fasting. This concept is obtained from the effect of Warburg, the opening of the Nobel Prize winner Otto Warburg, where cancer cells have abnormal glucose metabolism, even if oxygen.
Glutamine: Secret Fuel
The second fuel is glutamine, the amino acid that the tumors are used to continue to grow even during starvation of glucose. Glutamine supports key processes that water the growth of cancer cells and eliminates immune reactions.Dr. Seyfried claims that the combination of treatments that limit glucose and glutamine may become a promising approach to tumor growth, although he strongly prevents that such treatment should be carried out only by experienced specialists.
Do paradigms change or we cling to some new hope?
Determining cancer as a fundamentally metabolic disorder, Thomas sefride redorates the prevailing genetic paradigm in oncology. Although not the main one, his studies have caused excitement in the field of metabolic therapies, such as nutritional procedures and non -toxic, medicines containing metabolism.As an experienced scientist for many decades, Dr. Seifrid emphasizes that based on evidence, based on evidence, holistic strategies compared to the rights of assistance.While increasing attention is paid to metabolic cancer treatment strategies, these strategies should not displace basic therapy until they are tested at the clinic. Cancer is extremely personalized, and any diet modification or supplements should be carried out towards oncologists and doctors.Dr. Tomas Seifrid’s research continues to challenge traditional thinking and cancer treatment. Will this approach open new paradigms in oncology is an intriguing issue for the future of medical research.
